SCHEMBL6029256

SCHEMBL6029256

CN(C)CCCCCCCCCCC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 12/20 0.68
KDM4C Q9H3R0 12/20 0.68
KDM5A P29375 1/20 0.68
KDM7A Q6ZMT4 1/20 0.68
PHF8 Q9UPP1 1/20 0.68
KDM2A Q9Y2K7 1/20 0.68
TSHR P16473 4/20 0.60
LMNA P02545 2/20 0.60
NFKB1 P19838 1/20 0.60
PMP22 Q01453 1/20 0.60
ALDH1A1 P00352 2/20 0.55
PPARG P37231 3/20 0.54
PPARD Q03181 3/20 0.54
PPARA Q07869 3/20 0.54
GPR84 Q9NQS5 2/20 0.54
HDAC11 Q96DB2 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
TLR2 O60603 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1176587 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL13286331 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL5530872 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL28020165 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL219327 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL3402761 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL5219324 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
SCHEMBL8213501 1.00 KDM4A (0.68) KDM4AKDM4CKDM5AKDM7APHF8
Water SCHEMBL11318112 0.98 KDM4A (0.66) KDM4AKDM4CKDM5AKDM7APHF8
Hydrochloric Acid SCHEMBL247487 0.98 KDM4A (0.69) KDM4AKDM4CKDM5AKDM7APHF8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9606126-B2 Compositions and methods for membrane protein detergent stability screen UNIVERSITY OF VIRGINA PATENT FOUNDATION (US) 2017-03-28 US claimed
EP-0316809-B1 Salts of amino-(poly)percarboxylic acids AUSIMONT SPA (IT) 1993-11-03 EP claimed
EP-0316809-A2 Salts of amino-(poly)percarboxylic acids AUSIMONT S.p.A. (IT) 1989-05-24 EP claimed
EP-3810570-B1 SOLID SUPPORT NOVARTIS AG (CH) 2024-01-17 EP disclosed
US-10702603-B2 Methods and compositions for inactivating enveloped viruses BIOGEN MA INC. (US) 2020-07-07 US disclosed
US-20190175738-A1 METHODS AND COMPOSITIONS FOR INACTIVATING ENVELOPED VIRUSES BIOGEN MA INC. (US) 2019-06-13 US disclosed
US-10188732-B2 Methods and compositions for inactivating enveloped viruses BIOGEN MA INC. (US) 2019-01-29 US disclosed
US-20150306223-A1 METHODS AND COMPOSITIONS FOR INACTIVATING ENVELOPED VIRUSES BIOGEN IDEC MA INC. (US) 2015-10-29 US disclosed
US-20070054909-A1 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 US disclosed
US-7101683-B2 Methods for the simultaneous detection of HCV antigens and HCV antibodies ABBOTT LABORATORIES (US) 2006-09-05 US disclosed
US-6855809-B2 Methods for the simultaneous detection of HCV antigens and HCV antibodies ABBOTT LABORATORIES (US) 2005-02-15 US disclosed
US-6727092-B2 Methods for the simultaneous detection of HCV antigens and HCV antibodies ABBOTT LABORATORIES 2004-04-27 US disclosed
US-5423998-A Bleaching agent for detergent AUSIMONT S.R.L. (IT) 1995-06-13 US disclosed
US-5294362-A Bleach AUSIMONT S.R.L. (IT) 1994-03-15 US disclosed
EP-0316809-B1 Salts of amino-(poly)percarboxylic acids AUSIMONT SPA (IT) 1993-11-03 EP disclosed
US-5245075-A Bleaching agents AUSIMONT S.R.L. (IT) 1993-09-14 US disclosed
US-5243072-A Chemical intermediates TH. GOLDSCHMIDT AG (DE) 1993-09-07 US disclosed
US-5124446-A Hair care TH. GOLDSCHMIDT AG (DE) 1992-06-23 US disclosed
EP-0316809-A2 Salts of amino-(poly)percarboxylic acids AUSIMONT S.p.A. (IT) 1989-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070054909-A1 VLA-4 inhibitor compounds VCAM1, ITGB4, ICAM1 KDM4A 196/4885KDM4C 646/4885KDM5A 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.